Retrieve available abstracts of 50 articles: HTML format
Single Articles
June 2025
KOC HI, Dogan E, Yelkenci HE, Bayraktaroglu C, et al Circadian rhythm disruption exacerbates neurodegeneration and alters proteomic
profiles in a 6-OHDA induced Parkinson's disease model.
Exp Neurol. 2025 Jun 23:115356. doi: 10.1016/j.expneurol.2025.115356. PubMedAbstract available
XU Y, Zhang S, Mi J, Lu X, et al Modulatory effects of transcranial magneto-acoustic stimulation on behavior and
corticostriatal transmission of oscillatory activity in a mouse model of
Parkinson's disease induced by MPTP.
Exp Neurol. 2025;392:115352. PubMedAbstract available
May 2025
ZIKEREYA T, Liu C, Wei L, Wang Y, et al The cannabinoid receptor 1 mediates exercise-induced improvements of motor skill
learning and performance in parkinsonian mouse.
Exp Neurol. 2025 May 6:115289. doi: 10.1016/j.expneurol.2025.115289. PubMedAbstract available
PENG Y, Jiang DY, Yao SY, Zhang X, et al Gene-modified animal models of Parkinson's disease.
Exp Neurol. 2025;390:115287. PubMedAbstract available
MA J, Yang Y, Zang C, Chen Q, et al Inhibiting mitochondrial excessive fission alleviates the neuronal damage in
Parkinson's disease via regulating PGC-1alpha mediated mitochondrial biogenesis.
Exp Neurol. 2025 May 2:115288. doi: 10.1016/j.expneurol.2025.115288. PubMedAbstract available
April 2025
HONG JY, Lee JS, Kim SH, Lee PH, et al A model of L-DOPA-induced dyskinesia in parkinsonian mice produced by AAV
vector-mediated overexpression of alpha-synuclein.
Exp Neurol. 2025;389:115264. PubMedAbstract available
ZHANG Y, Liang C, Weng M, Zhang Z, et al Intestinal alterations of mucosal barrier integrity, motility and enteric nerve
in cynomolgus monkey model of Parkinson's disease.
Exp Neurol. 2025;389:115256. PubMedAbstract available
FENG N, Huang X, Jia Y Small extracellular vesicles from adipose derived stem cells alleviate microglia
activation and improve motor deficit of Parkinson's disease via
mir-100-5p/DTX3L/STAT1 signal axis.
Exp Neurol. 2025 Apr 5:115250. doi: 10.1016/j.expneurol.2025.115250. PubMedAbstract available
ZHANG L, Yan J, Song S, Yang Y, et al Detection of anxiety and depression-like behavior and intra-brain pathological
markers in Parkinsonian cynomolgus monkeys.
Exp Neurol. 2025;389:115242. PubMedAbstract available
March 2025
GAO Y, Liu W, Shi L, Yang P, et al Narirutin reduces microglia-mediated neuroinflammation by inhibiting the
JAK2/STAT3 pathway in MPP(+)/MPTP-induced Parkinson's disease models.
Exp Neurol. 2025;389:115232. PubMedAbstract available
February 2025
MIRANDA NC, Aquino YC, Macedo TO, Oliveira LM, et al Role of substantia Nigra dopaminergic neurons in respiratory modulation and
limitations of levodopa in Parkinson's disease.
Exp Neurol. 2025;387:115193. PubMedAbstract available
January 2025
LIANG JY, Yuan XL, Jiang JM, Zhang P, et al Targeting the NLRP3 inflammasome in Parkinson's disease: From molecular mechanism
to therapeutic strategy.
Exp Neurol. 2025 Jan 28:115167. doi: 10.1016/j.expneurol.2025.115167. PubMedAbstract available
LIU T, Wu H, Wei J Molecular insights into Parkinson's disease and type 2 diabetes mellitus:
Metformin's role and genetic pathways explored.
Exp Neurol. 2025;385:115137. PubMedAbstract available
QIAO CM, Ma XY, Tan LL, Xia YM, et al Indoleamine 2, 3-dioxygenase 1 inhibition mediates the therapeutic effects in
Parkinson's disease mice by modulating inflammation and neurogenesis in a gut
microbiota dependent manner.
Exp Neurol. 2025 Jan 8:115142. doi: 10.1016/j.expneurol.2025.115142. PubMedAbstract available
December 2024
MONNOT C, Kalomoiri M, MacNicol E, Kim E, et al Early alterations of functional connectivity, regional brain volumes and
astrocyte markers in the beta-sitosterol beta-d-glucoside (BSSG) rat model of
parkinsonism.
Exp Neurol. 2024 Dec 21:115118. doi: 10.1016/j.expneurol.2024.115118. PubMedAbstract available
HUANG XL, Hu Y, Jiang W, Jiang JM, et al Suppression of cGAS/STING pathway-triggered necroptosis in the hippocampus
relates H(2)S to attenuate cognitive dysfunction of Parkinson's disease.
Exp Neurol. 2024 Dec 3:115093. doi: 10.1016/j.expneurol.2024.115093. PubMedAbstract available
WANG H, Wu S, Jiang X, Li W, et al Acteoside alleviates salsolinol-induced Parkinson's disease by inhibiting
ferroptosis via activating Nrf2/SLC7A11/GPX4 pathway.
Exp Neurol. 2024 Dec 2:115084. doi: 10.1016/j.expneurol.2024.115084. PubMedAbstract available
DAADI MM, Snyder EY Exercise your graft - An important lesson for cell replacement therapy for
Parkinson's disease.
Exp Neurol. 2024 Dec 2:115085. doi: 10.1016/j.expneurol.2024.115085. PubMedAbstract available
November 2024
NAKAMURA K Editorial: Intersection of neural activity, synuclein and Parkinson's disease.
Exp Neurol. 2024 Nov 30:115091. doi: 10.1016/j.expneurol.2024.115091. PubMed
SERRA M, Faustini G, Brembati V, Casu MA, et al Early alpha-synuclein/synapsin III co-accumulation, nigrostriatal dopaminergic
synaptopathy and denervation in the MPTPp mouse model of Parkinson's Disease.
Exp Neurol. 2024 Nov 3:115040. doi: 10.1016/j.expneurol.2024.115040. PubMedAbstract available
October 2024
LI Z, Luo J, Li C, Zhu H, et al Upregulation of Nav1.6 expression in the ventral posterolateral nucleus of
thalamus contributes to hyperalgesia in a model of Parkinson's disease.
Exp Neurol. 2024 Oct 25:115032. doi: 10.1016/j.expneurol.2024.115032. PubMedAbstract available
ZHONG J, Yu X, Zhong Y, Tan L, et al GSK-3beta inhibitor amplifies autophagy-lysosomal pathways by regulating TFEB in
Parkinson's disease models.
Exp Neurol. 2024 Oct 25:115033. doi: 10.1016/j.expneurol.2024.115033. PubMedAbstract available
SHI Y, Zhang J, Xiu M, Xie R, et al The zona incerta system: Involvement in Parkinson's disease.
Exp Neurol. 2024 Oct 9:114992. doi: 10.1016/j.expneurol.2024.114992. PubMedAbstract available
September 2024
PAREKH P, Serra M, Allaw M, Perra M, et al Extract from Nasco pomace loaded in nutriosomes exerts anti-inflammatory effects
in the MPTP mouse model of Parkinson's disease.
Exp Neurol. 2024 Sep 18:114958. doi: 10.1016/j.expneurol.2024.114958. PubMedAbstract available
August 2024
BERNARD K, Mota JA, Wene P, Corenblum MJ, et al The angiotensin (1-7) glycopeptide PNA5 improvescognition in achronic progressive
mouse model of Parkinson's disease through modulation of neuroinflammation.
Exp Neurol. 2024 Aug 15:114926. doi: 10.1016/j.expneurol.2024.114926. PubMedAbstract available
NACCARATO MC, Oliveira LM, Ferreira CB, Moreira TS, et al Nucleus of the solitary tract neuronal degeneration and impaired hypoxia response
in a model of Parkinson's disease.
Exp Neurol. 2024 Aug 13:114924. doi: 10.1016/j.expneurol.2024.114924. PubMedAbstract available
July 2024
SAGREDO GT, Tanglay O, Shahdadpuri S, Fu Y, et al ?-Synuclein levels in Parkinson's disease - Cell types and forms that contribute
to pathogenesis.
Exp Neurol. 2024;379:114887. PubMedAbstract available
June 2024
KASANGA EA, Soto I, Centner A, McManus R, et al Moderate intensity aerobic exercise alleviates motor deficits in 6-OHDA lesioned
rats and reduces serum levels of biomarkers of Parkinson's disease severity
without recovery of striatal dopamine or tyrosine hydroxylase.
Exp Neurol. 2024;379:114875. PubMedAbstract available
LEI J, Tang LL, Jing R, You HJ, et al Antinociceptive role of the thalamic dopamine D3 receptor in descending
modulation of intramuscular formalin-induced muscle nociception in a rat model of
Parkinson's disease.
Exp Neurol. 2024 Jun 13:114846. doi: 10.1016/j.expneurol.2024.114846. PubMedAbstract available
April 2024
FERREIRA AFF, Ulrich H, Feng ZP, Sun HS, et al Neurodegeneration and glial morphological changes are both prevented by TRPM2
inhibition during the progression of a Parkinson's disease mouse model.
Exp Neurol. 2024;377:114780. PubMedAbstract available
March 2024
RUNWAL GM, Edwards RH The role of alpha-synuclein in exocytosis.
Exp Neurol. 2024;373:114668. PubMedAbstract available
February 2024
JACQUES WJ, Estelle M, Samuel G, Belkacem M, et al State-dependent alteration of respiration in a rat model of Parkinson's disease.
Exp Neurol. 2024 Feb 21:114740. doi: 10.1016/j.expneurol.2024.114740. PubMedAbstract available
FU X, Qu L, Xu H, Xie J, et al Ndfip1 protected dopaminergic neurons via regulating mitochondrial function and
ferroptosis in Parkinson's disease.
Exp Neurol. 2024;375:114724. PubMedAbstract available
January 2024
MAZZOCCO MT, Serra M, Maspero M, Coliva A, et al Positive relation between dopamine neuron degeneration and metabolic connectivity
disruption in the MPTP plus probenecid mouse model of Parkinson's disease.
Exp Neurol. 2024 Jan 26:114704. doi: 10.1016/j.expneurol.2024.114704. PubMedAbstract available
DAADI EW, Daadi ES, Oh T, Li M, et al Combining physical & cognitive training with iPSC-derived dopaminergic neuron
transplantation promotes graft integration & better functional outcome in
parkinsonian marmosets.
Exp Neurol. 2024 Jan 23:114694. doi: 10.1016/j.expneurol.2024.114694. PubMedAbstract available
SEILER JL, Zhuang X, Nelson AB, Lerner TN, et al Dopamine across timescales and cell types: Relevance for phenotypes in
Parkinson's disease progression.
Exp Neurol. 2024;374:114693. PubMedAbstract available
ESER P, Kocabicak E, Bekar A, Temel Y, et al Insights into neuroinflammatory mechanisms of deep brain stimulation in
Parkinson's disease.
Exp Neurol. 2024 Jan 8:114684. doi: 10.1016/j.expneurol.2024.114684. PubMedAbstract available
December 2023
CORSI S, Scheggi S, Pardu A, Braccagni G, et al Corrigendum to "Pregnenolone for the treatment of L-DOPA-induced dyskinesia in
Parkinson's disease" [Experimental neurology 2023 May;363:114370].
Exp Neurol. 2023 Dec 15:114640. doi: 10.1016/j.expneurol.2023.114640. PubMed
MANCHINU MF, Pala M, Palmas MF, Diana MA, et al Region-specific changes in gene expression are associated with cognitive deficits
in the alpha-synuclein-induced model of Parkinson's disease: A transcriptomic
profiling study.
Exp Neurol. 2023 Dec 11:114651. doi: 10.1016/j.expneurol.2023.114651. PubMedAbstract available
RADEMACHER K, Nakamura K Role of dopamine neuron activity in Parkinson's disease pathophysiology.
Exp Neurol. 2023 Dec 11:114645. doi: 10.1016/j.expneurol.2023.114645. PubMedAbstract available
ESER P, Kocabicak E, Bekar A, Temel Y, et al The interplay between neuroinflammatory pathways and Parkinson's disease.
Exp Neurol. 2023 Dec 5:114644. doi: 10.1016/j.expneurol.2023.114644. PubMedAbstract available
NIU B, Zhao M, Gao X, Xu J, et al TMT-based quantitative proteomics analysis of neuroprotective effects of
Forsythoside A on the MPTP-induced Parkinson's disease mouse model.
Exp Neurol. 2023 Dec 4:114642. doi: 10.1016/j.expneurol.2023.114642. PubMedAbstract available
November 2023
XIAO Z, Wang X, Pan X, Xie J, et al Mitochondrial iron dyshomeostasis and its potential as a therapeutic target for
Parkinson's disease.
Exp Neurol. 2023;372:114614. PubMedAbstract available
October 2023
BARCOMB K, Ford CP Alterations in neurotransmitter co-release in Parkinson's disease.
Exp Neurol. 2023;370:114562. PubMedAbstract available
August 2023
KASANGA EA, Han Y, Shifflet MK, Navarrete W, et al Nigral-specific increase in ser31 phosphorylation compensates for tyrosine
hydroxylase protein and nigrostriatal neuron loss: Implications for delaying
parkinsonian signs.
Exp Neurol. 2023;368:114509. PubMedAbstract available
KASANGA EA, Han Y, Navarrete W, McManus R, et al Differential expression of RET and GDNF family receptor, GFR-alpha1, between striatum
and substantia nigra following nigrostriatal lesion: A case for diminished
GDNF-signaling.
Exp Neurol. 2023;366:114435. PubMedAbstract available
June 2023
LIU Y, Liu H, Lu Y, Yin X, et al Non-invasive auditory and visual stimulation attenuates alpha-Synuclein deposition
and improves motor and non-motor symptoms in PD mice.
Exp Neurol. 2023;364:114396. PubMedAbstract available
May 2023
HART M, Conrad J, Barrett E, Legg K, et al X-linked hydrocephalus genes: Their proximity to telomeres and high a + T content
compared to Parkinson's disease.
Exp Neurol. 2023 May 6:114433. doi: 10.1016/j.expneurol.2023.114433. PubMedAbstract available
April 2023
RIVAS-SANTISTEBAN R, Lillo J, Raich I, Munoz A, et al The cannabinoid CB(1) receptor interacts with the angiotensin AT(2) receptor.
Overexpression of AT(2)-CB(1) receptor heteromers in the striatum of
6-hydroxydopamine hemilesioned rats.
Exp Neurol. 2023;362:114319. PubMedAbstract available
March 2023
SARA C, Simona S, Alessandra P, Giulia B, et al Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's
disease.
Exp Neurol. 2023 Mar 4:114370. doi: 10.1016/j.expneurol.2023.114370. PubMedAbstract available